{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:05:17Z","timestamp":1785942317697,"version":"3.56.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1212\/wnl.53.9.2082","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:42:43Z","timestamp":1336916563000},"page":"2082-2082","source":"Crossref","is-referenced-by-count":129,"title":["Visual dysfunction in patients receiving vigabatrin"],"prefix":"10.1212","volume":"53","author":[{"given":"N.R.","family":"Miller","sequence":"first","affiliation":[{"name":"From the Neuro-Ophthalmology Unit (Drs. MillerGirkin, and Perry, and M. Endres) and the Department of Neurology (Drs. Miller and Girkin, and S.R. Paul), the Johns Hopkins Medical Institutions, Baltimore, and the Maryland Center for Eye Care (Dr. Johnson), University of Maryland, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"From the Neuro-Ophthalmology Unit (Drs. MillerGirkin, and Perry, and M. Endres) and the Department of Neurology (Drs. Miller and Girkin, and S.R. Paul), the Johns Hopkins Medical Institutions, Baltimore, and the Maryland Center for Eye Care (Dr. Johnson), University of Maryland, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Paul","sequence":"additional","affiliation":[{"name":"From the Neuro-Ophthalmology Unit (Drs. MillerGirkin, and Perry, and M. Endres) and the Department of Neurology (Drs. Miller and Girkin, and S.R. Paul), the Johns Hopkins Medical Institutions, Baltimore, and the Maryland Center for Eye Care (Dr. Johnson), University of Maryland, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Girkin","sequence":"additional","affiliation":[{"name":"From the Neuro-Ophthalmology Unit (Drs. MillerGirkin, and Perry, and M. Endres) and the Department of Neurology (Drs. Miller and Girkin, and S.R. Paul), the Johns Hopkins Medical Institutions, Baltimore, and the Maryland Center for Eye Care (Dr. Johnson), University of Maryland, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Perry","sequence":"additional","affiliation":[{"name":"From the Neuro-Ophthalmology Unit (Drs. MillerGirkin, and Perry, and M. Endres) and the Department of Neurology (Drs. Miller and Girkin, and S.R. Paul), the Johns Hopkins Medical Institutions, Baltimore, and the Maryland Center for Eye Care (Dr. Johnson), University of Maryland, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Endres","sequence":"additional","affiliation":[{"name":"From the Neuro-Ophthalmology Unit (Drs. MillerGirkin, and Perry, and M. Endres) and the Department of Neurology (Drs. Miller and Girkin, and S.R. Paul), the Johns Hopkins Medical Institutions, Baltimore, and the Maryland Center for Eye Care (Dr. Johnson), University of Maryland, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.L.","family":"Krauss","sequence":"additional","affiliation":[{"name":"From the Neuro-Ophthalmology Unit (Drs. MillerGirkin, and Perry, and M. Endres) and the Department of Neurology (Drs. Miller and Girkin, and S.R. Paul), the Johns Hopkins Medical Institutions, Baltimore, and the Maryland Center for Eye Care (Dr. Johnson), University of Maryland, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb06003.x"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.1.54"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01251.x"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1567"},{"key":"e_1_3_1_6_2","unstructured":"Ben-Menachem  E French  J.  Vigabatrin.   In:  Engel J Pedley  TA eds. Epilepsy: a comprehensive textbook. Philadelphia:Lippincott\u2013Raven 1998:1609\u20131618."},{"key":"e_1_3_1_7_2","unstructured":"Fisher  RS Kerrigan  JF.  Vigabatrin: toxicity.   In:  Levy  RH Mattson  RH Meldrum  BS eds. Antiepileptic drugs. 4th ed.New York:Raven Press 1995:931\u2013939."},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7075.180"},{"key":"e_1_3_1_9_2","first-page":"1693.","volume":"314","year":"1997","unstructured":"Wilson EA, Brodie MJ. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:1693.","journal-title":"BMJ"},{"key":"e_1_3_1_10_2","first-page":"1693","volume":"314","year":"1997","unstructured":"Wong IC, Mawer GE, Sander JW. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:1693\u20131694.","journal-title":"BMJ"},{"key":"e_1_3_1_11_2","first-page":"1694.","volume":"314","year":"1997","unstructured":"Blackwell N, Hayllar J, Kelly G. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:1694.","journal-title":"BMJ"},{"key":"e_1_3_1_12_2","first-page":"1694.","volume":"314","year":"1997","unstructured":"Harding GF. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:1694.","journal-title":"BMJ"},{"key":"e_1_3_1_13_2","first-page":"179.","volume":"38","year":"1997","unstructured":"Kramer G, Scollo-Lavizzari G, Jallon P, et al. Vigabatrin-associated bilateral concentric visual field defects in four patients. Epilepsia 1997;38 (suppl 8):179.","journal-title":"Epilepsia"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.3.614"},{"key":"e_1_3_1_15_2","unstructured":"Zackon  DH Guberman  A Racette  L et al.  Vigabatrin and visual loss. Presented at the North American Neuro-Ophthalmology Society Meeting Orlando FL March 22\u201326 1998."},{"key":"e_1_3_1_16_2","first-page":"17.","volume":"20","year":"1998","unstructured":"Lawden MC, Eke T, Degg C, et al. Visual field constriction associated with vigabatrin treatment. Neuro-Ophthalmology 1998;20:17.","journal-title":"Neuro-Ophthalmology"},{"key":"e_1_3_1_17_2","first-page":"72.","volume":"39","year":"1998","unstructured":"Kalvianen R, Nousiainen I, Mantyjarvi M, et al. Initial vigabatrin monotherapy is associated with increased risk of visual field constriction: a comparative follow-up study with patients on initial carbamazepine monotherapy and healthy controls. Epilepsia 1998;39 (suppl 6):72.","journal-title":"Epilepsia"},{"key":"e_1_3_1_18_2","first-page":"817","volume":"116","year":"1998","unstructured":"Ruether K, Pung T, Kellner U, et al. Electrophysiologic evaluation of a patient with peripheral visual field constriction associated with vigabatrin. Arch Ophthalmol 1998;116:817\u2013819.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_1_19_2","unstructured":"Diabetic Retinopathy Study. Manual of operations. Baltimore: Diabetic Retinopathy Study Coordinating Center 1972."},{"key":"e_1_3_1_20_2","first-page":"33","volume":"198","year":"1980","unstructured":"Pourcho RG. Uptake of [H3]glycine and [H3]GABA by amacrine cells in the cat retina. Brain Res 1980;198:33\u201346.","journal-title":"Brain Res"},{"key":"e_1_3_1_21_2","first-page":"S1141.","volume":"38","year":"1997","unstructured":"Euler T, W\u00e4ssle H. Different contribution of GABA(A) and GABA(C) receptors to rod and cone bipolar cells in the rat retinal slice. Invest Ophthalmol Vis Sci 1997;38:S1141.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_1_22_2","first-page":"S980.","volume":"39","year":"1998","unstructured":"Kapousta-Bruneau N. GABAA and GABAC receptor antagonists have opposite effects on the b-wave of ERG in rat retina. Invest Ophthalmol Vis Sci 1998;39:S980.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/full\/10.1212\/WNL.53.9.2082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T13:06:17Z","timestamp":1711544777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.53.9.2082"}},"subtitle":["Clinical and electrophysiologic findings"],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["10.1212\/WNL.53.9.2082"],"URL":"https:\/\/doi.org\/10.1212\/wnl.53.9.2082","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}